Cannabis Potency Increases as Daily Use Exceeds Alcohol Consumption

Users of high-potency cannabis products are reporting severe addiction struggles that contradict earlier assumptions the substance is not habit-forming. One 18-year-old described rummaging through a public dumpster hours after discarding her THC vape cartridge, then later retrieving the same item from a full garbage bag in her apartment after it had been thrown into an outdoor dumpster.

She said she has attended rehab, undergone therapy for years, given away products, changed schools and made non-smoking friends but has been unable to quit despite daily efforts. The subreddit r/leaves dedicated to quitting cannabis has more than 400,000 followers.

The author joined the group late last year after acknowledging that near-daily use, sometimes multiple times a day, was harming daily life. Recreational cannabis is now legal in about half of U.S. states and medical use is permitted in nearly every state.

A 2024 study found that for the first time more Americans consume some form of cannabis daily than alcohol. According to the Centers for Disease Control and Prevention, an estimated 30 percent of cannabis users develop addiction. Cannabis use disorder is defined as continued use despite negative consequences for 12 months or more, along with spending excessive time obtaining or thinking about the substance and unsuccessful quit attempts.

THC, the main psychoactive component, stimulates dopamine release in the brain's reward system. Heavy users experience a sharp drop in dopamine during withdrawal, which can drive continued use. The risk of developing cannabis use disorder is higher for those who begin before age 25, use frequently, or have mental health conditions or genetic predispositions.

One individual described getting sick with what was likely the virus in March 2020 in New York City before widespread testing, then turning to cannabis out of fear and boredom. Shared rituals such as rolling joints or consuming edibles created a sense of connection that later shifted to solitary daily use after job loss and financial strain.

The same person began selling personal belongings to fund the habit and chose cannabis over groceries at times. A spouse noted increased clumsiness, forgetfulness, emotional distance and excessive sleep. Paranoia, disorientation and derealization returned in later stages of heavy use.

The individual suspected the habit was reducing ambition, harming memory and limiting the ability to create art or improve life circumstances. A 33-year-old father said cannabis initially helped him stop using alcohol and other drugs but became impossible to quit after his first child was born.

He reported destroying smoking devices and cutting off dealers without success, describing feelings of emptiness without the substance that always led to relapse.

and Research Findings

Today's cannabis products contain far higher THC concentrations than those available decades ago. Typical THC levels were around 4 percent 50 years ago but now average near 20 percent in street products, with dispensary concentrates reaching 95 percent.

Newer studies indicate roughly one in three users may develop cannabis use disorder compared with earlier estimates of one in 10. Research has identified clear brain changes in heavy users exposed to high THC levels over time. Frequent use is associated with increased emergency room visits for cannabinoid hyperemesis syndrome, which causes severe vomiting and abdominal pain, as well as impacts on memory and executive function.

Growing links have also been observed between high-THC products and psychosis, especially among younger users. A drug policy researcher stated there is a persistent misunderstanding that cannabis is not addictive because many users never develop problems.

The researcher added that cannabis is a dependence-producing substance and that a significant share of frequent users report interference with their lives. A review of cannabinoids for mental health treatment found no evidence of efficacy for anxiety, depression or PTSD, the three most common conditions for which it is prescribed.

The postdoctoral fellow who co-authored the March review reported being accused of pharmaceutical industry ties despite no such funding, noting instead that cannabis has become a major commercial enterprise. A 22-year-old who recently stopped described insomnia, night sweats, loss of appetite and irritability that eased after several days, though feelings of emptiness and emotional flatness persisted for weeks or months.

One person who quit after years of near-constant use reported vivid dreams turning into night terrors, inability to eat or sleep, and an initial sense that life would never feel enjoyable again. After passing through an early period of heightened optimism known as the pink cloud, the individual noted improved attention span, renewed ability to create art, reduced depression and anxiety, and replacement of former habits with exercise, classes and outdoor activities.

A woman who quit in her mid-60s after more than 40 years of regular use advised addressing underlying reasons for consumption. She recently began pursuing a childhood interest in learning drums that had been discouraged in her youth. An addiction psychiatrist stated that cannabis can affect brain development into the early 30s.

Medical experts emphasized that immediate effects may temporarily relieve psychological distress but do not address underlying conditions over the long term. The author, now several months cannabis-free, reported that confronting obligations previously avoided while using has been difficult but ultimately beneficial.

Both the author and others who quit described missing the substance at times while working to replace it with sustainable activities and routines.